Alfredo Rivas-Delgado

Alfredo Rivas-Delgado: Review on treating high-risk MCL patients by Anita Kumar

Alfredo Rivas-Delgado, Research Fellow at Memorial Sloan Kettering Cancer, posted on X/Twitter:

“A comprehensive review on treating high-risk MCL patients by Anita Kumar

– High Ki67, TP53mut, blastoid morphology, POD24
– Targeted therapy including BTKi + BCL2inh + antiCD20
– Promising data with CAR-T and BsAbs
– Refer early to tertiary centers.“

Source: Alfredo Rivas-Delgado/X

Alfredo Rivas-Delgado Anita Kumar blastoid morphology cancer CAR-T and BsAbs High Ki67 high-risk MCL patients OncoDaily Oncology POD24 targeted therapy tertiary centers TP53mut